Alpine Woods Capital Investors’s Abiomed Inc ABMD Stock Holding History

Alpine Woods Capital Investors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,000	Closed	-$277K	–	249
2020 Q3	$277K	Hold	1,000	–	–	0.04%	214
2020 Q2	$242K	Buy	+1,000	New	+$201K	0.05%	228
2019 Q3	–	Sell	-1,000	Closed	-$260K	–	282
2019 Q2	$260K	Hold	1,000	–	–	0.05%	243
2019 Q1	$286K	Hold	1,000	–	–	0.06%	224
2018 Q4	$325K	Hold	1,000	–	–	0.08%	206
2018 Q3	$450K	Hold	1,000	–	–	0.09%	163
2018 Q2	$409K	Hold	1,000	–	–	0.09%	162
2018 Q1	$291K	Buy	+1,000	New	+$253K	0.02%	340

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Alpine Woods Capital Investors's ABMD Position: Q4 2020 in Review

Alpine Woods Capital Investors sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 1,000 shares — an estimated $277K sold.

Alpine Woods Capital Investors first reported a position in ABMD in Q1 2018 and held it in 8 quarters. The position peaked at $450K in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Alpine Woods Capital Investors reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 1,000 Abiomed Inc shares in Q4 2020, an estimated $277K.
Alpine Woods Capital Investors first reported a position in Abiomed Inc in Q1 2018 and held it in 8 quarters.
Alpine Woods Capital Investors's Abiomed Inc position peaked at $450K in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2020, filed 1 Feb 2021.